CATALOGO DEI PRODOTTI DELLA RICERCA

To report the results of a national survey aimed at quantifying the current level of diffusion of Levodopa/carbidopa intestinal gel (LCIG) in Italy.

Which patients discontinue? Issues on Levodopa/carbidopa intestinal gel treatment: Italian multicentre survey of 905 patients with long-term follow-up

TAMBURIN, Stefano;
2017-01-01

Abstract

To report the results of a national survey aimed at quantifying the current level of diffusion of Levodopa/carbidopa intestinal gel (LCIG) in Italy.
2017
Levodopa-carbidopa intestinal gel infusion; Neuropathy; Parkinson's disease; Withdrawal; Antiparkinson Agents; Carbidopa; Disease Progression; Drug Combinations; Female; Gels; Health Surveys; Humans; Intestines; Italy; Levodopa; Longitudinal Studies; Male; Parkinson Disease; Retrospective Studies; Substance Withdrawal Syndrome
01.01 Articolo in Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/963897
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 45
  • ???jsp.display-item.citation.isi??? 42
social impact